| Region: | |
| Category: |
(20 reports matching your criteria)
|
Calming and Sleeping in Australia
3/7/2013 | published by: Euromonitor International
... and 65, much of which is the result of women reaching menopause. With the number of Australians aged 50-65 increasing each year, this is fuelling the growth of calming and sleeping products. Euromonitor International's Calming ...
|
read more...
|
$900.00
|
|
PharmaPoint: Prostate Cancer - Australia Drug Forecast and Market Analysis to 2022
12/31/2012 | published by: GlobalData
... of second-line metastatic castration-resistant prostate cancer (mCRPC) therapies like J&J’s Zytiga (abiraterone acetate) and Medivation/Astellas’ Xtandi (enzalutamide) will drive strong market growth over the next decade. These safe and orally administered treatments will provide safety ...
|
read more...
|
$4,995.00
|
|
New Zealand Anesthesia and Respiratory Devices Market Outlook to 2018 - Respiratory Devices, Respiratory Measurement Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others
11/30/2012 | published by: GlobalData
... Respiratory Devices Market Outlook to 2018 - Respiratory Devices, Respiratory Measurement Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others” provides key market data on the New Zealand Anesthesia and Respiratory Devices ...
|
read more...
|
$2,500.00
|
|
Australia Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery
9/30/2012 | published by: GlobalData
... the Australia Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The ...
|
read more...
|
$2,500.00
|
|
New Zealand Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery
9/30/2012 | published by: GlobalData
... data on the New Zealand Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and ...
|
read more...
|
$2,500.00
|
|
Calming and Sleeping in New Zealand
3/8/2012 | published by: Euromonitor International
... products that help to provide a good night’s sleep. Steady growth also points to the fact that an increasing number of individuals have busy and stressful lives and that sleeping disorder incidence is on the ...
|
read more...
|
$900.00
|
|
Health and Wellness in Australia
11/2/2011 | published by: Euromonitor International
... increasing number of consumers switching from standard products to better for you (BFY) reduced fat, reduced sugar and naturally healthy (NH) high fibre products. NH high fibre products are not only less fattening than standard ...
|
read more...
|
$1,900.00
|
|
Hot Topics in Diabetes: the future of antidiabetics in Australia
9/29/2011 | published by: Datamonitor
... diabetes. Introduction The diagnosed diabetic population in Australia is growing, and patients are continuing to struggle to reach and maintain target blood glucose levels. These market drivers, combined with a preponderance of safety concerns over ...
|
read more...
|
$3,800.00
|
|
Hot Topics in Diabetes: the future of antidiabetics in Australia
9/29/2011 | published by: Datamonitor
... antidiabetics in recent years, means that the opportunity for new and improved pipeline candidates is lucrative.Provides insight into the key drivers and resistors to antidiabetic drug uptake in Australia Analyzes the current diabetes treatment paradigm ...
|
read more...
|
$3,800.00
|
|
Calming and Sleeping in Australia
7/4/2011 | published by: Euromonitor International
... health issue in Australia. The economic impact is A$10.3 billion annually. Euromonitor International's Calming and Sleeping in Australia report offers a comprehensive guide to the size and shape of the market at a national level. ...
|
read more...
|
$900.00
|
|
Epidemiology: Diabetes in Australia - Despite government efforts to promote healthy lifestyles, the number of cases of diabetes in Australia is set to soar
6/17/2011 | published by: Datamonitor
... The major epidemiologic drivers for diabetes in Australia are population growth, the aging population, increases in underlying obesity, and decreased physical activity. Introduction Gain insight to market potential, including a robust 10-year epidemiology forecast of ...
|
read more...
|
$5,700.00
|
|
Calming and Sleeping in New Zealand
5/27/2011 | published by: Euromonitor International
... aware of the importance of adequate rest and a good night’s sleep has increased. It also indicates that the amount of people who lead busy and stressful lifestyles in New Zealand, which cause sleep disorders, ...
|
read more...
|
$900.00
|
|
Calming and Sleeping - New Zealand
7/14/2010 | published by: Euromonitor International
... and the growing number of redundancies increased everyday stress, causing sleep problems. Euromonitor International's Calming and Sleeping in New Zealand report offers a comprehensive guide to the size and shape of the market at a ...
|
read more...
|
$900.00
|
|
OTC Obesity - New Zealand
7/14/2010 | published by: Euromonitor International
... Zealand Ltd is still the only OTC obesity product available in the New Zealand market. Euromonitor International's OTC Obesity in New Zealand report offers a comprehensive guide to the size and shape of the market ...
|
read more...
|
$900.00
|
|
Calming and Sleeping - Australia
6/15/2010 | published by: Euromonitor International
... medications resulting from a highly publicised accidental overdose in the preceding year. Euromonitor International's Calming and Sleeping Products in Australia report offers a comprehensive guide to the size and shape of the market at a ...
|
read more...
|
$900.00
|
|
OTC Obesity - Australia
6/15/2010 | published by: Euromonitor International
... confirmation by the latest National Health Survey (2007-08) that one quarter of the country’s adults are obese and an additional 37% of the adult population are overweight. Euromonitor International's OTC Obesity Products in Australia report ...
|
read more...
|
$900.00
|
|
Commercial Insight: Asthma/COPD in Australia
5/20/2010 | published by: Datamonitor
... will be me-too products or combinations of existing classes, Datamonitor assumes that these will be priced similarly to current brands in order to receive reimbursement, leading to a stabilizing market. Scope Forecast for marketed and ...
|
read more...
|
$5,700.00
|
|
Asthma/COPD in Australia Market Forecast
5/20/2010 | published by: Datamonitor
... will be me-too products or combinations of existing classes, Datamonitor assumes that these will be priced similarly to current brands in order to receive reimbursement, leading to a stabilizing market. Reasons to Purchase Identify opportunities ...
|
read more...
|
$5,700.00
|
|
Opportunities Assessment for Diabetes Therapeutics - Australia
12/23/2008 | published by: Frost & Sullivan
... provide an update on the epidemiology of T2 diabetes, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the diabetes therapeutics market in Australia.
|
read more...
|
$6,000.00
|
|
Strategic Analysis of the Australian Sleep Apnea Therapeutics Markets
11/25/2005 | published by: Frost & Sullivan
... optimal capacity and still deal with a waiting list that stretches from one to three months. The current lab infrastructure is grossly inadequate to treat the approximately 482,000 obstructive sleep apnea (OSA) patients. On an ...
|
read more...
|
$6,000.00
|
